HealthEquity (NASDAQ:HQY) EVP Sells 108 Shares of Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Sunil Rajasekar sold 108 shares of the stock in a transaction on Monday, August 24th. The stock was sold at an average price of $105.60, for a total value of $11,404.80. Following the sale, the executive vice president directly owned 53,297 shares in the company, valued at approximately $5,628,163.20. This trade represents a 0.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Sunil Rajasekar also recently made the following trade(s):

• On Thursday, October 15th, Sunil Rajasekar purchased 108 shares of HealthEquity stock. The stock was bought at an average price of $90.33 per share, for a total transaction of $9,755.64.

HealthEquity Price Performance

HQY stock traded up $1.04 during midday trading on Monday, reaching $93.07. The company had a trading volume of 532,932 shares, compared to its average volume of 944,347. The company has a market capitalization of $7.70 billion, a price-to-earnings ratio of 33.60, a price-to-earnings-growth ratio of 1.45 and a beta of 0.24. The stock has a 50 day moving average price of $96.08 and a 200-day moving average price of $91.47. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.05. The business had revenue of $350.73 million during the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company’s quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities research analysts expect that HealthEquity, Inc. will post 3.93 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on HQY. Weiss Ratings raised shares of HealthEquity from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Barclays lifted their price objective on shares of HealthEquity from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Friday, September 18th. Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a research report on Friday, August 28th. Finally, Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $112.20.

Hedge Funds Weigh In On HealthEquity

A number of institutional investors have recently added to or reduced their stakes in the stock. Oxbow Advisors LLC bought a new position in HealthEquity in the 1st quarter valued at approximately $3,147,000. Maridea Wealth Management LLC acquired a new stake in shares of HealthEquity during the 2nd quarter valued at $2,753,000. Deutsche Bank AG acquired a new stake in shares of HealthEquity during the 2nd quarter valued at $11,986,000. Amundi grew its position in HealthEquity by 33.6% during the 2nd quarter. Amundi now owns 90,327 shares of the company’s stock worth $8,158,000 after acquiring an additional 22,735 shares during the last quarter. Finally, Bamco Inc. NY bought a new stake in HealthEquity during the 2nd quarter worth $67,776,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.